Medical microbiology
Detection of biofilm production in candida species from blood stream patients
Keywords:
biofilm production, candida species, blood stream patientsAbstract
Candida species are the fourth most common cause of bloodstream infections and are the leading cause of invasive fungal infections among hospitalized patients [1]. Candidemia is a life-threatening fungal infection associated with a mortality rate of 38%; [2].The spectrum of candidemia has changed with the emergence of non- albicans Candida (NCAC) species, a strain with the threat of increased mortality especially in immunocompromised and severely ill patients [4]. It is very important to identify Candida to the species level to optimize the selection of the antifungal agent. More importantly, intrinsic and emerging resistance represents a major challenge for empirical, therapeutic and prophylactic strategies. Candida species have also been isolated from the respiratory tract, mouth, skin, ear and eye. Candida is a true opportunistic pathogen that under certain circumstances is able to invade tissues normally resistant to infection.
Downloads
References
Manolakaki D, Velmahos G, Kourkoumpetis T, Chang Y, Alam H B, De Moya M M, & Mylonakis E. Candida infection and colonization among trauma patients. Virulence, 2010;1(5):367-375.
Kourkoumpetis, Themistoklis m K., et al. The effect of cumulative length of hospital stay on the antifungal resistance of Candida strains isolated from critically ill surgical patients. Mycopathologia 2011; (171.2): 85-91.
K. Fugelsang, C. Edwards Wine Microbiology Second Edition,Springer Science and Business Media , New York (2010) ; 3–28: 0387333495
Spanakis, Elias K., et al. Statin Therapy and Decreased Incidence of Positive Candida Cultures Among Patients With Type 2 Diabetes Mellitus Undergoing Gastrointestinal Surgery. Mayo Clinic Proceedings. 2010; Vol. 85:No. 12.
Nguyen NH, Suh SO, Blackwell M Five novel Candida species in insect- associated yeast clades isolated from Neuroptera and other insects. Mycologia(2007); 99 (6):842858: 10.3852/mycologia.99.6.842:183 3-3508.
Suh SO, Nguyen NH, Blackwell M Yeasts isolated from plant-associated beetles and other insects: seven novel Candida species near Candida albicans. FEMS Yeast (2008);8 (1): 88–102: 10.1111.1567- 1364.2007:00320.x17986254.
dEnfert C; Hube B Candida: Comparative and Functional Genomics. Caister Academic Press. (2007);978-1-904455-13-4.
"Candidiasis". cdc.gov. February 13, 2014;28 December 2014.
"Symptoms of Oral Candidiasis". February 13, 2014; 28 December 2014. 10.Symptoms of Genital / Vulvovaginal Candidiasis". cdc.gov. February 13, 2014; 28 December 2014.
Jurden L, Buchanan M, Kelsberg G, Safranek S ,Clinical inquiries. Can probiotics safely prevent recurrent vaginitis. The Journal of family practice (June 2012); 61 (6): 357, 368: PMID 22670239.
Goehring, Richard V. Mims' medical microbiology. (4th ed.). Philadelphia, PA: Mosby Elsevier. (2008); p. 656: ISBN 978-0-323-04475-2.
Bassetti M, Mikulska M, Viscoli C Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit. Critical Care(December 2010); 14 (6): 244. 10.1186/cc9239. 21144007.
Odds FC Candida infections: an overview". Crit. Rev. Microbiol. (1987); 15 (1): 1–5. 10.3109/10408418709104444: 3319417.
Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP Nosocomial blood stream infections in United States hospitals: a three- year analysis. Clinical Infection 1999;29:239–44 10:1086/520192
Wisplinghoff H, Bischoff T, Tallent S, Seifert H, Wenzel R, Edmond M Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. 2004;39:309–17 10.1086/421946
Eggimann P, Garbino J, Pittet D Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. 2003;3:685– 702 10.1016/S1473-3099(03)00801-6
Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP Hospital- acquired candidemia: the attributable mortality and excess length of stay. 1988;148:2642–5 10.1001/148.12.2642
Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, et al. Attributable mortality of nosocomial candidemia, 2003;37:1172–7 10.1086/378745.
Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. 2005;41:1232–9 10.1086/496922
Bagge N, Ciofu O, Skovgaard L T, Hoiby N. Rapid development in vitro and in vivo of resistance to ceftazidime in biofilm- growing Pseudomonas aeruginosa due to chromosomal β- lactamase. APMIS.2000;108:589–600.
Chandra J, Mukherjee P K, Leidich S D, Faddoul F F, Hoyer L L, Douglas L J, Ghannoum M A. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res. 2001;80:903–908
Xu K D, McFeters G A, Stewart P S. Biofilm resistance to antimicrobial agents. Microbiology.2000;146:547–549.
Wey S B, Mori M, Pfaller M A, Woolson R F, Wenzel R P. Hospital- acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med. 1988;148:2642–2645.
Odds, F.C., and R. Bernaerts. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. 1923-1929; 32.
Almon L, Stovall WD. Serologic reactions of cultures of Monilia and some yeastlike fungi. Journal of Infectious Diseases 2014; 55: 12–25.
Anderson ML, Odds FC. Adherence of Candida albicans to vaginal epithelia: significance of morphological form and effect of ketoconazole. Mykosen . (1985); 28: 531–540.
Woods JW, Manning IH, Patterson CN. Monilial infections complicating the therapeutic use of antibiotics. Journal of the American Medical Association (1951); 145: 207–211.
"Candida species". DoctorFungus.org. Archived from the original on 2007-02-08; 2007-02-09.
Socransky SS, Haffajee AD. Dental biofilms: difficult therapeutic targets. Periodontol.2000;2008(28):12–55
Douglas, L. J. . Candida biofilms and their role in infection. Trends Microbiol. (2003); 11:30-36.
Douglas, L. J. Medical importance of biofilms in Candida infections.Rev. Iberoam. Micol. (2002); 19:139-143
Kumamoto, C. A. . Candida biofilms. Curr. Opin. Microbiol. (2002); 5:608-611.
S. P., H. Norris, C. J. Jessup, and M. A. Ghannoum. . Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H- tetrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J. Clin. Microbiol. 1998; 36:1450-1452.
Ellier, R., M. Krajden, G. A. Grigoriew, and I. Campbell. . Innovative endpoint determination system for antifungal susceptibility testing of yeasts.Antimicrob. Agents Chemother. 1992.
Ramage, G., K. Vande Walle, B. L. Wickes, and J. L. Lopez-Ribot. . Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. (2001); 45:2475-2479
Morgan, J. Global trends in candidemia: review of reports from 1995- 2005; Curr. Infect. 7:429-439.
Morgan, J., M. I. Meltzer, B. D. Plikaytis, A. N. Sofair, S. Huie-White, S. Wilcox, L. H. Harrison, E. C. Seaberg, R. A. Hajjeh, and S. M. Teutsch. 2005; Excess mortality, hospital stay, and cost due to candidemia: a case- control study using data from population-based candidemia surveillance. Infect. Control. Hosp. Epidemiol. 26:540-547.
MedlinPfaller, M. A., and D. J. Diekema. Epidemiology of invasive candidiasis: a persistent public health problem 2014; 20:133-163.
Gudlaugsson, O., S. Gillespie, K. Lee, J. Vande Berg, J. Hu, S. Messer, L. Herwaldt, M. Pfaller, and D. Diekema. . Attributable mortality of nosocomial candidemia , 2001; 37:1172-1177.
Kojic, E. M., and R. O. Darouiche.. Candida infections of medical devices.2004;l 17:255-267.
Kuhn, D. M., J. Chandra, P. K. Mukherjee, and M. A. Ghannoum. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. 2000; 70:878-888
Pfaller, M. A., D. J. Diekema, R. N. Jones, H. S. Sader, A. C. Fluit, R. J. Hollis, S. A. Messer, and The SENTRY Participant Group. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program.39:3254-3259.
Ramage, G., S. P. Saville, D. P. Thomas, and J. L. Lopez-Ribot.. Candida biofilms: an update. Eukaryot. Cell 2005; 4:633-638
Reid G. Biofilms in infectious disease and on medical devices. Int. J. Antimic Ag 1999;11:223-6.
Etest Application Sheet for Yeast EAS. AB Biodisk, Dalvagen 2006 ;10, S-169 56 Nucci M, Marr KA. Emerging fungal diseases. Clin Infect Dis 2005;41:521-6
Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: 2001;33:177-86
Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: 2001;33:177-86
Shoham S, Shaffer R, Sweet L, Cooke R, Donegan N, Boyce S. Candidemia in patients with ventricular assist devices 2007;44:e9-12.
Gordon SM, Schmitt SK, Jacobs M, Smedira NM, Goormastic M, Banbury MK. Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. 2001;72:725-30.
Walsh TJ, Rex JH. All catheter-related candidemia is not the same: Assessment of the balance between the risks and benefits of removal of vascular catheters. 2002;34:600-2.
Heitner SB, Eiger G, Fischer R, Scott EC, Somers A. Risk factors for candidemia: Comparison between medical and surgical intensive care unit patients. 2005;128:379S-80.
Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999; 2002;35:627-30
Malani A, Hmoud J, Chiu L, Carver PL, Bielaczyc A, Kauffman CA. Candida glabrata fungemia: Experience in a tertiary care center. Clin Infect Dis 2005;41:975
Bretagne, S., and J.-M. Costa.. Towards a molecular diagnosis of invasive aspergillosis and disseminated candidosis. FEMS Immunol. Med. Microbiol. 2005; 45:361–368
Espy, M. J., J. R. Uhl, L. M. Sloan, S. P. Buckwalter, M. F. Jones, E. A. Vetter, J. D. Yao, N. L. Wengenack, J. E. Rosenblatt, F. R. Cockerill III, and T. F. Smith.. Real-time PCR in clinical microbiology: applications for routine laboratory testing. 2006; 19:165–256.
Ferns, R. B.. Evaluation of the role of real-time PCR in the diagnosis of invasive aspergillosis. Leuk. Lymphoma 2006; 47:15–20.
Davey M E, O'Toole G A. Microbial biofilms: from ecology to molecular genetics. Microbiol. 2000;64:847–867.
O'Toole G, Kaplan H B, Kolter R. Biofilm formation as microbial development. Annu Rev Microbiol.2000;54:49–79.
Watnick P, Kolter R. Biofilm, city of microbes. J Bacteriol. 2000;182:2675–2679.
Reynolds T B, Fink G R. Bakers' yeast, a model for fungal biofilm formation. Science. 2001;291:878–881.
Makihira S, Nikawa H, Tamagami M, Hamada T, Nishimura H,Ishida K, et al. Bacterial and Candida adhesion to intact anddenatured collagen in vitro. 2002;45(9–10):389–92.14
Bowman BJ, Bowman EJ. H+-ATPases from mitochondria, plasma membranes, and vacuoles of fungal cells. Journal ofMembrane Biology 1986;94(2):83–97.12.
Poul Erik Peterson , Continuous Improvement of oral health in the 21st Century – the approach of the WHO Global Oral Health Programme; World Oral Health Report , WHO/NMH/NPH/ORH/03.2
L. Li, S. Redding, A. Dongari-Bagtzoglou. Candida glabrata, an emerging oral opportunistic pathogen. (2007); 86: 204
M. Belazi, A. Velegraki, T. Koussidou-Eremondi, D. Andrealis, S. Hini, G. Arsenis, C. Eliopoulou, E.Destouni, D. Antoniades. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer:prevalence, azole susceptibility profiles and response to antifungal treatment. Oral Microbiol Immunol (2004); 19: 347
A.N. Davies, S. Brailsford, K. Broadley, D. Beighton. Oral yeast carriage in patients with advanced cancer. (2002); 17: 79.
N. S. Soysa, L. P. Samaranayake, and A. N. B. Ellepola, ―Antimicrobials as a contributory factor in oral candidosis—a brief overview,Oral Diseases, 2008; vol. 14: no. 2, pp. 138–143,
R. Rautemaa, P. Rusanen, M. Richardson, J.H. Meurman. Optimal sampling site for mucosal candidosis in oral cancer patients is the labial sulcus. J Med Microbiol, (2006); 55: 1447.
P. Rousselle, A. M. Freydiere, P. J. Couillerot, H. De Montclos, and Y. Gille, ―Rapid identification of Candida albicans by using albicans ID and fluoroplate agar plates, Journal of Clinical Microbiology,. 1994; 32: 12, 3034–3036.
D. J. Sullivan, T. J. Westerneng, K. A. Haynes, D. E. Bennett, and D. C. Coleman, ―Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV- infected individuals, 1995 141: 7, 1507–1521,.
Odds FC. Candida and Candidosis. 2nd Ed Bailliere Tindail, London England, 1988; 68: 93-114,.
Grazia Cagetti 1, Stefano Mastroberardino 1, Egle Milia 2, Fabio Cocco 3, Peter Lingström 4 and Guglielmo The Use of Probiotic Strains in Caries Prevention: A Systematic Review Maria CampusWHO Collaborating Centre of Milan for Epidemiology and Community Dentistry, Department of Health Sciences, University of Milan, Milan 2014; 2: 2013; 5: 2530- 2550;:10.3390/5072530
Rangaraj S., Uyen B., Ajit P. L. et al. Rapid identification of commonly encountered Candida species directly from blood culture bottles. J Clin. Microbial. (2012); 41 : 5660 - 5664.
Helmi H. and Gad A. 2002. Rapid diagnosis of candidemia by species specific nested PCR. Egyp. J. Med.Microbiol. 2005; 11 (2): 429-439. 4. Savikivi E., Lyytikainen O., Soll D.R. et al.
Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit. J Clin. Microbial.43: 2729-2735.
Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. 41: 1232- 1239. 2
Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP Hospital acquired candidemia: The attributable mortality and excess lengthy of stay. 148: 2642-2645.
Schelenz S Management of candidiasis in the intensive care unit. J Antimicrob Chem 61: i31-34. 4.
Horvath LL, Hospenthal DR, Murray CK, Dooley DP Direct isolation of Candida species from blood cultures on the chromogenic medium CHROMAgar 41: 2629-2632
D. Dhanasekaran et al on Human dental biofilm: Screening, characterization in vitro biofilm formation and antifungal resistance of Candida spp
Jagadish Chander, Text book of Medical Mycology, Mehta publishers; 3rd ed,Secvii,AppendixB,Conventional Mycological Techniques: 2011; 516.
Jagadish Chander, Text book of Medical Mycology, Mehta publishers; 3rd ed,Secvii,AppendixC,Conventional Mycological Techniques: 2008; 522- 530.
Jagadish Chander, Text book of Medical Mycology, Mehta publishers; 3rd ed,Secvii,AppendixA,Conventional Fungal culture media 2008; 522-530
Khan ZU, Ahmad S, Mokaddas E, Al-Sweih N, Chandy R. Sunflower seed husk agar: A new medium for the differentiation of Candida dubliniensis from Candida albicans. 2005;23:182-5.
Betty A. Forbes, Daniel F. Sahm, Alice S. Weissfeld. Bailey & scott’sDiagnostic Microbiology,; International edition,12th ed.Part- 5,Mycology,Chapter- 50, Laboratory Method in Basic Mycology, Procedure 50-9:710.
Haley, Leanor D. & Callaway, Carey S, June.Laboratory Method in Medical Mycology, U.S. Department of Health, Education and welfare, Centre for Disease Control 1978;119.
Mycology Laboratory Procedure Manual, Mayo Clinic D,1979; 117
Rochester, Minnesota, Robert, Glenn.Laboratory Procedure in Clinical Microbiology, Washington, John A, Mayo Clinic, Rochester, Minnesota, 1981;429-430.
John A, Mayo Clinic, Rochester, Minnesota Laboratory Procedure in Clinical Microbiology, Washington, 1981; 429-430.
Jagadish Chander, Text book of Medical Mycology, Mehta publishers; 3rd ed, Secvii, Appendix A, Fungal culture Media: 2011 512.
Jagadish Chander, Text book of Medical Mycology, Mehta publishers; 2011 3rd 86 ed,chapter 20
Hawser SP, Douglas LJ. Biofilm formation of Candida species on the surface of catheter materials in vitro. Infect Immun. 1994;62:915–21.
Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: A persistent public health problem. 2007;20:133-63.
Xess I, Jain N, Hasan F, Mandal P, Banerjee U. Epidemiology of candidemia in a tertiary care centre of north India: 5-year study. Infection 2007;35:256-9.
Samaranayake LP, Lamb AB, Lamey PJ, MacFarlane TW. Oral carriage of Candida species and coliforms in patients with burning mouth syndrome. J Oral Pathol 1989;18:233—5.
Branchini ML, Pfaller MA, Rhine-Chalberg J, Frempong T, Isenberg HD. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. 1994;32:452—6.
Samaranayake LP, Cheung LK, Samaranayake YH. Candidiasis and other fungal diseases of the mouth. Dermatol Ther 2002;15:252—70.
D. M. Kuhn,J. Chandra,1P. K. Mukherjee,and M. A. Ghannoum, Comparison of Biofilms Formed by Candida albicans and Candida parapsilosison Bioprosthetic Surfaces 70(2): 878–888.
Afreenish Hassan, Javaid Usman, Fatima Kaleem,Maria Omair, Ali Khalid, Muhammad Iqbal,Evaluation of different detection methods of biofilm formation in the clinical isolates1413-8670
Susanne Weber, Marco Hebestreit, Torsten Wilms, Lynda L. Conroy, Gregory Rodrigo, Comet assay and air–liquid interface exposure system: A new combination to evaluate genotoxic effects of cigarette whole smoke in human lung cell lines2013; 10.1016/..06.016
M. O. Pereira M. J. Vieira L. F. MeloA simple floe cell for monitioring biofilm formation in laboratory and industrial 4700-057
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
